Affinity Asset Advisors, LLC Nls Pharmaceutics Ltd. Transaction History

Affinity Asset Advisors, LLC

  • $579 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.7 - $1.42 $139,681 - $283,353
-199,545 Reduced 49.89%
200,455 $140,000
Q2 2023

Aug 14, 2023
BUY
$0.92 - $1.56 $51,438 - $87,221
55,911 Added 16.25%
400,000 $440,000
Q1 2023

May 15, 2023
BUY
$1.26 - $1.82 $433,552 - $626,241
344,089 New
344,089 $523,000

About NLS Pharmaceutics Ltd.

NLSP Quotes by TradingView
  • Ticker NLSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,349,900
  • Market Cap $55.5M
  • Description
  • NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...
More about NLSP
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email